VCM
NVCR icon

Versant Capital Management’s NovoCure NVCR Stock Holding History

Versant Capital Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$183K Sell
12,093
-3,173
-21% -$48K 0.02% 660
2026
Q1 		$166K Buy
15,266
+10,200
+201% +$127K 0.02% 656
2025
Q4 		$65.5K Buy
5,066
+1,444
+40% +$18.5K 0.01% 949
2025
Q3 		$46.8K Sell
3,622
-13,637
-79% -$182K 0.01% 1077
2025
Q2 		$307K Buy
17,259
+3,560
+26% +$62K 0.05% 312
2025
Q1 		$244K Buy
13,699
+10,358
+310% +$235K 0.04% 356
2024
Q4 		$99.6K Buy
3,341
+880
+36% +$18.6K 0.02% 316
2024
Q3 		$38.5K Sell
2,461
-556
-18% -$10.1K 0.01% 549
2024
Q2 		$51.7K Buy
3,017
+2,917
+2,917% +$51.3K 0.01% 366
2024
Q1 		$1.56K Buy
+100
New +$1.47K ﹤0.01% 1427
2023
Q4 		– Sell
-35
Closed -$565 – 1981
2023
Q3 		$565 Buy
35
+33
+1,650% +$951 ﹤0.01% 1668
2023
Q2 		$83 Sell
2
-4
-67% -$248 ﹤0.01% 2034
2023
Q1 		$361 Hold
6
– – ﹤0.01% 1634
2022
Q4 		$440 Hold
6
– – ﹤0.01% 1448
2022
Q3 		$0 Hold
6
– – ﹤0.01% 1574
2022
Q2 		$0 Hold
6
– – ﹤0.01% 1576
2022
Q1 		$0 Sell
6
-2
-25% -$147 ﹤0.01% 1572
2021
Q4 		$1K Hold
8
– – ﹤0.01% 1315
2021
Q3 		$1K Buy
8
+2
+33% +$302 ﹤0.01% 1329
2021
Q2 		$1K Hold
6
– – ﹤0.01% 1331
2021
Q1 		$1K Hold
6
– – ﹤0.01% 1404
2020
Q4 		$1K Hold
6
– – ﹤0.01% 1238
2020
Q3 		$0 Hold
6
– – ﹤0.01% 1434
2020
Q2 		$0 Hold
6
– – ﹤0.01% 1473
2020
Q1 		$0 Hold
6
– – ﹤0.01% 1560
2019
Q4 		$0 Hold
6
– – ﹤0.01% 1512
2019
Q3 		$0 Hold
6
– – ﹤0.01% 1522
2019
Q2 		$0 Buy
+6
New +$304 ﹤0.01% 1611

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Versant Capital Management's NVCR Position: Q2 2026 in Review

Versant Capital Management reduced its NovoCure (NVCR) stake by 21% in Q2 2026, selling an estimated $48K and leaving 12,093 shares worth $183K. The position accounts for 0.02% of the portfolio, ranked #660.

Versant Capital Management first reported a position in NVCR in Q2 2019 and has held it in 28 quarters since. The position peaked at $307K in Q2 2025. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • Versant Capital Management held 12,093 shares of NovoCure worth $183K as of Q2 2026.
  • Versant Capital Management sold 3,173 NovoCure shares in Q2 2026, an estimated $48K.
  • NovoCure made up 0.02% of Versant Capital Management's portfolio in Q2 2026, its #660 holding.
  • Versant Capital Management first reported a position in NovoCure in Q2 2019 and has held it in 28 quarters since.
  • Versant Capital Management's NovoCure position peaked at $307K in Q2 2025.
  • 218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.